In vitro Assessment of the Effects of Silybin on CYP2B6-mediated Metabolism
Planta Medica · 01.10.2023 · 89 (13) · 1195-1203
DOI: 10.1055/a-2102-0648 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.10.2023. Verfasst von Wenwen Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacy Administration, Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Wes…. Hauptthemen laut MEDLINE: Silybin, Cytochrome P-450 CYP2B6, Silymarin, Cytochrome P-450 CYP2B6 Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Silybin is a flavonol compound with a variety of physiological properties, such as hepatoprotective, anti-fibrogenic, and hypocholesterolemic effects. Although the in vivo and in vitro effects of silybin are frequently reported, studies on herb–drug interactions have yet to be performed. With the discovery of multiple important substrates of CYP2B6 recently, there is a growing body of evidence indicating that CYP2B6 plays a much larger role in human drug metabolism than previously thought. The purpose of this study is to determine how silybin affects the CYP2B6 enzymeʼs activity, as well as to clarify the molecular mechanisms for inhibition by silybin. The results showed that silybin inhibited CYP2B6 activity in liver microsomes in a non-competitive manner, with IC50 and Ki values of 13.9 µM and 38.4 µM, respectively. Further investigations revealed that silybin could down-regulate the expression of CYP2B6 protein in HepaRG cells. The hydrogen bond conformation of silybin in the active site of the CYP2B6 isoform was revealed by a molecular docking study. Collectively, our findings verify that silybin is an inhibitor of CYP2B6 and explain the molecular mechanism of inhibition. This can lead to a better understanding of the herb–drug interaction between silybin and the substrates of the CYP2B6 enzyme, as well as a more rational clinical use of silybin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy and Pharmacy Administration, Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, West China School of Pharmacy, Sichuan University, Chengdu, China.
- Deparment of Pharmacy, Xi'an Children's Hospital, The Affiliated Children Hospital of Xi'an Jiaotong University, Xi'an, China.
Zitieren
APA
Zhang, W., Zhang, Y., Wen, C., Jiang, X., & Wang, L. (2023). In vitro Assessment of the Effects of Silybin on CYP2B6-mediated Metabolism. Planta Medica, 89(13), 1195-1203. https://doi.org/10.1055/a-2102-0648
Vancouver
Zhang W, Zhang Y, Wen C, Jiang X, Wang L. In vitro Assessment of the Effects of Silybin on CYP2B6-mediated Metabolism. Planta Medica. 2023;89(13):1195-1203. doi:10.1055/a-2102-0648
BibTeX
@article{Zhang2023,
author = {Zhang, Wenwen and Zhang, Yice and Wen, Chengming and Jiang, Xuehua and Wang, Ling},
title = {In vitro Assessment of the Effects of Silybin on CYP2B6-mediated Metabolism},
journal = {Planta Medica},
year = {2023},
volume = {89},
number = {13},
pages = {1195--1203},
doi = {10.1055/a-2102-0648}
}
EUVIMED